Results
|
1.
|
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW. MedStar authors:
Year: 2016
Citation: - Journal of Clinical Endocrinology & Metabolism. 101(5):2056-62, 2016 May
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D
|
|
2.
|
|
|
3.
|
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors:
Year: 2014
Citation: - Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T
|
|
4.
|
Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW. MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(6):1706-11, 2014 Jun.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D
|
|
5.
|
Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro. [] MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(8):2317-25, 2014 Aug.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Ahren B, Chow FC, Fonseca VA, Gross JL, Harmony 6 Study Group, Johnson SL, Leiter LA, Miller D, Ratner RE, Rosenstock J, Stewart MW, Yang F
|
|
6.
|
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Endocrinology & Metabolism. 100(5):1855-62, 2015 May.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Adam KP, Banerji M, Bray GA, Buchanan TA, Clement SC, Cobb JE, DeFronzo RA, Ferrannini E, Gall W, George T, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D
|
|
7.
|
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors:
Year: 2013
Citation: - Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D
|
|
8.
|
Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). MedStar authors:
Year: 2012
Citation: - The International Journal of Cardiovascular Imaging. 28(3):455-65, 2012 Mar.
Institution: - MedStar Health Research Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - APPROACH study group, Brugaletta S, Garcia-Garcia HM, Garg S, Huang C, Kolatkar NS, Kravitz BG, Miller DM, Morocutti G, Nesto RW, Ratner RE, Serruys PW
|
|
9.
|
Sitagliptin: an oral agent for glucose control. MedStar authors:
- Bardsley, Joan
- Ratner, Robert E
Year: 2008
Citation: - Expert Review of Endocrinology & Metabolism. 3(6):691-697, 2008 Nov.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department: - AVP, Core Scientific Services
Medline publication type:
|
|
10.
|
The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. MedStar authors:
- Aroda, Vanita R
- Ratner, Robert E
Year: 2015
Citation: - Journal of Clinical Endocrinology & Metabolism. 100(4):1646-53, 2015 Apr.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Observational Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Ackermann RT, Aroda VR, Barrett-Connor E, Christophi CA, Delahanty LM, Diabetes Prevention Program Research Group, Edelstein SL, Herman WH, Knowler WC, Montez MG, Ratner RE, Zhang P, Zhuo X
|
|
11.
|
Gestational diabetes: implications for cardiovascular health. [Review] MedStar authors:
- Ratner, Robert E
- Sullivan, Shannon D
- Umans, Jason G
Year: 2012
Citation: - Current Diabetes Reports. 12(1):43-52, 2012 Feb.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Medline publication type:
All authors: - Ratner R, Sullivan SD, Umans JG
|
|
12.
|
Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes. MedStar authors:
- Aroda, Vanita R
- Fernandez, Stephen J
- Ratner, Robert E
Year: 2013
Citation: - Diabetes Technology & Therapeutics. 15(2):117-23, 2013 Feb.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Aroda VR, Conway BN, Fernandez SJ, Matter NI, Maynard JD, Orchard TJ, Ratner RE
|
|
13.
|
|
|
14.
|
PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY. MedStar authors:
- Howard, Barbara V
- Howard, Wm James
- Mete, Mihriye
- Ratner, Robert E
- Silverman, Angela
- Umans, Jason G
- Weissman, Neil J
Year: 2009
Citation: - Journal of Clinical Lipidology. 3(5):322-331, 2009 Oct 01.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department: - Medicine/Internal Medicine
Medline publication type:
All authors: - Howard WJ, Russell M, Fleg JL, Mete M, Ali T, Devereux RB, Galloway JM, Otvos JD, Ratner RE, Roman MJ, Silverman A, Umans JG, Weissman NJ, Wilson C, Howard BV
|